AIM ImmunoTech amends CEO/COO employment: CEO salary $650k plus $100k stock

AIM ImmunoTech Inc.

CEO Equels: cash salary reduced to $650,000, plus $100,000 in restricted shares for one year ending Sept 11, 2025.
COO Rodino: base salary $375,000 plus $50,000 in shares; period corrected to one year ending Aug 12, 2025.
Amendment corrects prior duration error in August 2024 compensation changes for both officers.
Shares valued at 100% of Sept 10, 2024 closing price; compensation committee approved the revisions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.